MAPT and Alzheimer disease: Prophylactic treatment of 3xTg-AD mice with ibuprofen at 6 months of age showed a significant decrease in intraneuronal oligomeric Aβ and hyperphosphorylated tau immunoreactivity in the hippocampus, and reduced the cognitive decline compared to untreated 3xTg-AD mice13.